Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Resistance Mutations in Hepatitis B Virus (HBV)-HIV-Coinfected Patients Treated for HBV Chronic Infection Once Daily with 10 Milligrams of Adefovir Dipivoxil Combined with Lamivudine

Adefovir dipivoxil (ADV) at a suboptimal concentration for human immunodeficiency virus type 1 (HIV-1) (10 mg once daily) can be used to treat hepatitis B virus (HBV) infection in HIV-1-HBV-coinfected patients and does not, even in the case of uncontrolled HIV-1 replication, select for either ADV mu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Delaugerre, Constance, Marcelin, Anne-Geneviève, Thibault, Vincent, Peytavin, Gilles, Bombled, Tony, Bochet, Marie-Valérie, Katlama, Christine, Benhamou, Yves, Calvez, Vincent
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC127167/
https://ncbi.nlm.nih.gov/pubmed/11959607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.5.1586-1588.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars